In contrast to the short and self-terminating activation of NF-κB in acute-phase response situations [31, 32], the activation of NF-κB has been suggested to participate in chronic disorders, including diabetic patients with a new onset of diabetes or a long history of diabetes [15, 33, 34]. This evidence concerns the gene NFKB1 and diabetes mellitus.